Extracellular matrix molecule chondroitin sulfate proteoglycans (CSPGs) are highly upregulated in scar tissues and form a potent chemical barrier for CNS axon regeneration. Recent studies support that the receptor protein tyrosine phosphatase σ (PTPσ) and its subfamily member leukocyte common antigen related phosphatase (LAR) act as transmembrane receptors to mediate CSPG inhibition. PTPσ deficiency increased regrowth of ascending axons into scar tissues and descending corticospinal tract (CST) axons into the caudal spinal cord after spinal cord injury (SCI). Pharmacological LAR inhibition enhanced serotonergic axon growth in SCI mice. However, transgenic LAR deletion on axon growth in vivo and the role of LAR in regulating regrowth of other fiber tracts have not been studied. Here, we studied the role of LAR in restricting regrowth of injured descending CNS axons in deficient mice. LAR deletion increased regrowth of serotonergic axons into scar tissues and caudal spinal cord after dorsal over-hemitransection. LAR deletion also stimulated regrowth of CST fibers into the caudal spinal cord. LAR protein was upregulated days to weeks after injury and co-localized to serotonergic and CST axons. Moreover, LAR deletion improved functional recovery by increasing BMS locomotor scores and stride length and reducing grid walk errors. This is the first transgenic study that demonstrates the crucial role of LAR in restricting regrowth of injured CNS axons.
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Introduction
Failure of CNS axons to regenerate after injury has been ascribed to a non-permissive environment and a developmental reduction in intrinsic growth capacity (Busch and Silver, 2007; Goldberg et al., 2002; McGee and Strittmatter, 2003) . Among the extrinsic factors, chondroitin sulfate proteoglycans (CSPGs) are highly upregulated by reactive scar tissues and strongly suppress axon extension into and beyond the lesion by forming a non-permissive perineuronal nets with other extracellular matrix molecules (Bradbury et al., 2002; Busch and Silver, 2007; Jones et al., 2003) . Although the potent inhibitory property of CSPGs on neuronal regeneration has been identified for over two decades (McKeon et al., 1991; Snow et al., 1990) , the underlying molecular mechanisms are not well understood. The inhibitory actions of CSPGs depend on sulfation pattern of their glycosaminoglycan (GAG) chains because preventing GAG sulfation eliminates most of the inhibitory activity on axon growth in vitro (Gilbert et al., 2005; Sherman and Back, 2008; Wang et al., 2008) . CSPGs may mediate suppression of axon growth by several mechanisms, including binding and activating functional transmembrane receptors, sterically hindering growth-promoting adhesion molecules, and facilitating inhibitory effects of chemo-repulsive molecules (Condic et al., 1999; Kantor et al., 2004; Tan et al., 2011) . Although CSPGs may hinder function of matrix molecules non-specifically, several receptors appear to be important in conveying CSPG inhibition, including PTPσ, LAR, Nogo receptor (NgR) 1 and 3 (Dickendesher et al., 2012; Fisher et al., 2011; Shen et al., 2009 ). In particular, PTPσ and LAR, two members in the LAR subfamily, could bind CSPGs with high affinity and mediate their suppression of axon elongation.
PTPσ deficiency in adult mice increased regrowth of sensory axons into scar tissues and CST axons into the caudal spinal cord after injury (Dickendesher et al., 2012; Shen et al., 2009) . Pharmacological blockade of LAR with small peptides stimulated regrowth of 5-HT axons (Fisher et al., 2011) . However, many critical issues regarding CSPG receptor function remain unclear, including validation of LAR function on axon growth in vivo by a transgenic approach. In this study, we studied the effect of LAR deletion on CNS axonal regeneration and functional Neurobiology of Disease 73 (2015) 36-48 
